Aurora Cannabis (ACB) Share-based Compensation (2017 - 2025)
Aurora Cannabis (ACB) reported Share-based Compensation of -$395114.5 for Q4 2025, down 133.31% year-over-year from $1.2 million in Q4 2024, and down 110.94% quarter-over-quarter from $3.6 million in Q3 2025.
Aurora Cannabis (ACB) Share-based Compensation (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Share-based Compensation data on file, last reported at -$395114.5 in Q4 2025.
- Share-based Compensation for Q4 2025 came in at -$395114.5, down 133.31% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.5 million (down 33.47% YoY), and the FY2025 annual result was $8.0 million, down 14.9% from the prior year.
- Share-based Compensation retreated to -$395114.5 in Q4 2025 per ACB's latest filing, from $3.6 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $4.1 million in Q1 2021 and troughed at -$395114.5 in Q4 2025.
- A 5-year average of $2.5 million and a median of $2.5 million in 2021 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2023 and 2025: Share-based Compensation jumped 55.22% in 2023, then tumbled 133.31% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $3.1 million in 2021, then climbed by 1.93% to $3.2 million in 2022, then tumbled by 33.88% to $2.1 million in 2023, then sank by 43.12% to $1.2 million in 2024, then plunged by 133.31% to -$395114.5 in 2025.
- Business Quant data shows ACB's Share-based Compensation at -$395114.5 in Q4 2025, $3.6 million in Q3 2025, and $1.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 9.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -395,114.54 |
| Dec 31, 2025 | -395,114.54 |
| Sep 30, 2025 | 3.61 Mn |
| Sep 30, 2025 | 3.61 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 3.41 Mn |
| Sep 30, 2023 | 3.41 Mn |